Y Intercept Hong Kong Ltd Acquires Shares of 6,768 U.S. Physical Therapy, Inc. (NYSE:USPH)

Y Intercept Hong Kong Ltd purchased a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 6,768 shares of the company's stock, valued at approximately $573,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State Street Corp raised its stake in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after buying an additional 99,244 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company's stock worth $6,425,000 after purchasing an additional 61,474 shares during the last quarter. Southernsun Asset Management LLC grew its holdings in U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock valued at $46,302,000 after buying an additional 52,062 shares in the last quarter. Penn Davis Mcfarland Inc. purchased a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $2,552,000. Finally, Rockefeller Capital Management L.P. increased its holdings in shares of U.S. Physical Therapy by 18.8% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company's stock worth $13,578,000 after buying an additional 25,393 shares during the last quarter.

Insider Buying and Selling

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now directly owns 20,469 shares of the company's stock, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Nancy Ham sold 1,172 shares of the firm's stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares in the company, valued at $107,552.64. The trade was a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,412 shares of company stock valued at $706,605 in the last ninety days. Company insiders own 1.70% of the company's stock.

U.S. Physical Therapy Trading Down 0.6 %

U.S. Physical Therapy stock traded down $0.60 during midday trading on Friday, reaching $93.46. 89,624 shares of the stock traded hands, compared to its average volume of 106,030. The firm has a market cap of $1.41 billion, a PE ratio of 99.43, a price-to-earnings-growth ratio of 4.23 and a beta of 1.46. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a 50-day simple moving average of $89.32 and a two-hundred day simple moving average of $89.89. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.88%. The ex-dividend date was Friday, November 15th. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 187.23%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Bank of America reaffirmed a "neutral" rating and issued a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st. Barrington Research reiterated an "outperform" rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Finally, JPMorgan Chase & Co. upped their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Tuesday, December 3rd.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.